Connective tissue growth factor immunohistochemical expression is associated with gallbladder cancer progression

Archives of Pathology and Laboratory Medicine

Volumn 137, Issue 2, 2013, Pages 245-250

  Garcia, Patricia ^a,c   Leal, Pamela ^a   Alvarez, Hector ^b   Brebi, Priscilla ^a   Ili, Carmen ^a   Tapia, Oscar ^a   Roa, Juan C ^a,c  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CTGF PROTEIN, HUMAN;

ARTICLE; CANCER INVASION; CHOLECYSTITIS; DISEASE COURSE; FEMALE; GALLBLADDER; GALLBLADDER TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TISSUE MICROARRAY;

CHOLECYSTITIS; CONNECTIVE TISSUE GROWTH FACTOR; DISEASE PROGRESSION; FEMALE; GALLBLADDER; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; TISSUE ARRAY ANALYSIS;

EID: 84874670919     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2011-0628-OA     Document Type: Article

References (40)

1. Miller G, Jarnagin WR. Gallbladder carcinoma. Eur J Surg Oncol. 2008; 34(3): 306-312.
2. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118(7): 1591-1602.
3. Meng H, Wang X, Fong Y, Wang ZH, Wang Y, Zhang ZT. Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases. Jpn J Clin Oncol. 2011;41(8): 992-998.
4. Lee SE, Jang JY, Lim CS, Kang MJ, Kim SW. Systematic review on the surgical treatment for T1 gallbladder cancer. World J Gastroenterol. 2011;17(2): 174-180.
5. Harada K, Ochiai T, Inoue K, et al. Optimal surgical treatment for patients with pT2 gallbladder cancer. Hepatogastroenterology. 2011;58(105): 14-19.
6. Roa I, de Aretxabala X, Araya JC, et al. Morphological prognostic elements in gallbladder cancer [in Spanish]. Rev Med Chil. 2002;130(4): 387-395.
7. Sergeant G, Lerut E, Ectors N, Hendrickx T, Aerts R, Topal B. The prognostic relevance of tumor hypoxia markers in resected carcinoma of the gallbladder. Eur J Surg Oncol. 2011;37(1): 80-86.
8. Liu DC, Yang ZL. Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma. Pathol Res Pract. 2011;207(8): 472-478.
9. Varga M, Obrist P, Schneeberger S, et al. Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clin Cancer Res. 2004;10(9): 3131-3136.
10. Chen CC, Lau LF. Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol. 2009;41(4): 771-783.
11. Chu CY, Chang CC, Prakash E, Kuo ML. Connective tissue growth factor (CTGF) and cancer progression. J Biomed Sci. 2008;15(6): 675-685.
12. Bennewith KL, Huang X, Ham CM, et al. The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Cancer Res. 2009;69(3): 775-784.
13. Mao Z, Ma X, Rong Y, et al. Connective tissue growth factor enhances the migration of gastric cancer through downregulation of E-cadherin via the NFkappaB pathway. Cancer Sci. 2011;102(1): 104-110.
14. Liu LY, Han YC, Wu SH, Lv ZH. Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer. World J Gastroenterol. 2008;14(13): 2110-2114.
15. Lin BR, Chang CC, Che TF, et al. Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer. Gastroenterology. 2005;128(1): 9-23.
16. Chang CC, Shih JY, Jeng YM, et al. Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis. J Natl Cancer Inst. 2004; 96(5): 364-375.
17. Chien W, Yin D, Gui D, et al. Suppression of cell proliferation and signaling transduction by connective tissue growth factor in non-small cell lung cancer cells. Mol Cancer Res. 2006;4(8): 591-598.
18. Alvarez H, Corvalan A, Roa JC, et al. Serial analysis of gene expression identifies connective tissue growth factor expression asaprognostic biomarker in gallbladder cancer. Clin Cancer Res. 2008;14(9): 2631-2638.
19. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
20. Kayahara M, Nagakawa T, Nakagawara H, Kitagawa H, Ohta T. Prognostic factors for gallbladder cancer in Japan. Ann Surg. 2008;248(5): 807-814.
21. Zuo GW, Kohls CD, He BC, et al. The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis. Histol Histopathol. 2010;25(6): 795-806.
22. Dhar A, Ray A. The CCN family proteins in carcinogenesis. Exp Oncol. 2010;32(1): 2-9.
23. Zhou ZQ, Cao WH, Xie JJ, et al. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer. 2009;9: 291.
24. Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel RE. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer. 2004;11(4): 781-791.
25. Chen PP, Li WJ, Wang Y, et al. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer. PLoS One. 2007;2(6):e534.
26. Gardini A, Corti B, Fiorentino M, et al. Expression of connective tissue growth factor isaprognostic marker for patients with intrahepatic cholangiocarcinoma. Dig Liver Dis. 2005;37(4): 269-274.
27. Kular L, Pakradouni J, Kitabgi P, Laurent M, Martinerie C. The CCN family: a new class of inflammation modulators? Biochimie. 2010;93(3): 377-388.
28. Schottenfeld D, Beebe-Dimmer J. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin. 2006;56(2): 69-83.
29. Tazuma S, Kajiyama G. Carcinogenesis of malignant lesions of the gall bladder: the impact of chronic inflammation and gallstones. Langenbecks Arch Surg. 2001;386(3): 224-229.
30. Wistuba, II, Gazdar AF. Gallbladder cancer: lessons fromarare tumour. Nat Rev Cancer. 2004;4(9): 695-706.
31. Kitamura K, Kasuya K, Tsuchida A, et al. Immunohistochemical analysis of transforming growth factor beta in gallbladder cancer. Oncol Rep. 2003;10(2): 327-332.
32. Shi JS, Zhou LS, Han Y, Zhu AJ, Sun XJ, Yang YJ. Expression of tumor necrosis factor and its receptor in gallstone and gallbladder carcinoma tissue. Hepatobiliary Pancreat Dis Int. 2004;3(3): 448-452.
33. Kim H, Song JY, Cho JY, et al. Strong cytoplasmic expression of COX2 at the invasive fronts of gallbladder cancer is associated withapoor prognosis. J Clin Pathol. 2010;63(12): 1048-1053.
34. Asano T, Shoda J, Ueda T, et al. Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression. Clin Cancer Res. 2002;8(4): 1157-1167.
35. Kawamoto T, Shoda J, Asano T, et al. Expression of cyclooxygenase-2 in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder. Int J Cancer. 2002;98(3): 427-434.
36. Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y, Leask A. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem. 2000;275(20): 15220-15225.
37. Shi-Wen X, Leask A, Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev. 2008;19(2): 133-144.
38. Hartel M, Di Mola FF, Gardini A, et al. Desmoplastic reaction influences pancreatic cancer growth behavior. World J Surg. 2004;28(8): 818-825.
39. Karger A, Fitzner B, Brock P, et al. Molecular insights into connective tissue growth factor action in rat pancreatic stellate cells. Cell Signal. 2008;20(10): 1865-1872.
40. Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, Rowley DR. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res. 2005;65(19): 8887-8895.